Diabetic Nephropathy: From Bench to Bedside | Agenda Bookshop Skip to content
Online orders placed from 19/12 onward will not arrive in time for Christmas.
Online orders placed from 19/12 onward will not arrive in time for Christmas.
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Dr Mingxi Mingxi Li
B01=Jianling Tao
B01=Xuemei Li
Category1=Non-Fiction
Category=MJGD
Category=MJR
COP=United States
Delivery_Delivery within 10-20 working days
Language_English
PA=In stock
Price_€100 and above
PS=Active
softlaunch

Diabetic Nephropathy: From Bench to Bedside

English

Diabetic Nephropathy (DN) is the leading cause to end-stage renal disease all over the world. Unfortunately, no effective treatment is available to stop its progression. So far, many key issues remain unrevealed in relation to its pathogenesis, new forms of therapy, and complication intervention. In this book, the authors aim to provide updated medical knowledge and practical management strategies to medical professionals who are caring for DN patients based on their ample clinical experiences, strong bench and bedside research background, and tight collaboration with experts in other fields caring for common complications in DN. The authors also want to shed light on the work of bench researchers in fields of DN and its complications from a clinical perspective. See more
Current price €103.22
Original price €110.99
Save 7%
Age Group_Uncategorizedautomatic-updateB01=Dr Mingxi Mingxi LiB01=Jianling TaoB01=Xuemei LiCategory1=Non-FictionCategory=MJGDCategory=MJRCOP=United StatesDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=In stockPrice_€100 and abovePS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Weight: 208g
  • Dimensions: 155 x 230mm
  • Publication Date: 01 Dec 2016
  • Publisher: Nova Science Publishers Inc
  • Publication City/Country: United States
  • Language: English
  • ISBN13: 9781536102772
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept